Biscayne Neurotherapeutics Stock

biscayneneuro.comHealthcareFounded: 2017Funding to Date: $9MM

Biscayne Neurotherapeutics is a clinical-stage biotechnology company developing novel therapies for difficult-to-treat neurological disorders.

Register for Details

For more details on financing and valuation for Biscayne Neurotherapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Biscayne Neurotherapeutics.

Register Today

Team

Management Team

Jared Mendel
Director, Finance and Administration
Stephen Collins Ph.D
Chief Executive Officer & President
Samuel Reich
Executive Chairman & Co-Founder

Board Members

Warren Lammert
Carey Ng Ph.D
Mesa Verde Venture Partners
Samuel Reich
Zafrira Avnur Ph.D
Quark Venture

Other companies like Biscayne Neurotherapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM